Skip to content
MarketScale
‹ Back to IndustriesSciences

Expanding Monitoring in Acute Care and Beyond

This episode is part three of EY's five-part Health and Life Sciences at the Edge series, exploring how hospitals can expand patient monitoring beyond the ICU across the full care continuum. It addresses the challenge of scaling monitoring capabilities without adding alarm fatigue or increased burden for clinicians. The discussion focuses on strategies for smarter, more connected monitoring that supports better patient outcomes.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Michelle Dawn Mooney · Acute CareAi in HealthcareAlarm FatigueAmbient Monitoring
Share

Key takeaways

01

Expanding monitoring beyond the ICU requires balancing broader coverage with clinician workload management.

02

Alarm fatigue remains a critical barrier to effective patient monitoring at scale.

03

This is part of a broader EY series examining the future of health and life sciences at the edge of care.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

As hospitals look beyond the ICU to improve outcomes across the entire continuum of care, a key question emerges: how do you expand patient monitoring without overwhelming clinicians with more alarms, more noise, and more work? This episode—part three of a five-part Health and Life Sciences at the Edge series exploring The Future of Patient Monitoring—dives into what it will take to make continuous monitoring practical, scalable, and clinically meaningful beyond critical care. Intel’s Andrew Lamkin, AI Solutions Architect, joins Sudha Yellapantula, Senior Researcher at Medical Informatics Corp., in conversation with Michelle Dawn Mooney to unpack how analytics, wearables, and wireless infrastructure are reshaping acute care and beyond.

Yellapantula explains that today’s most advanced monitoring still lives almost exclusively in ICUs, while other hospital areas rely on infrequent spot checks. “If you go to areas where patients are generally more stable… they take a blood pressure once in eight hours,” she notes. That gap creates risk. “There are areas where you could benefit from having more continuous monitoring and you don’t. And then you miss something, and then it’s an emergency.” Expanding monitoring, however, introduces a new challenge: signal overload. Without intelligent filtering, continuous data everywhere quickly becomes noise.

The conversation centers on how analytics must evolve alongside monitoring. “If you put continuous monitoring everywhere, it’s noise,” Yellapantula explains, emphasizing that clinician attention is finite. The goal is not more data, but better prioritization. Strong analytics help zero in on the patients who truly need attention, enabling earlier intervention without burning out care teams. “Clinicians… you can only overload and damage,” she says, reinforcing the need for predictive insights rather than reactive alarms.

Lamkin and Yellapantula also explore what will actually move the needle. While wearables and wireless connectivity are essential, Yellapantula is clear that AI is the differentiator—if the data foundation is strong. “You cannot build AI without good data,” she says, pointing to the joint optimization of sensors, connectivity, and compute. Looking ahead, she envisions a future where AI offloads cognitive burden from clinicians, synthesizing patient history and signals into clear, actionable briefings. “The doctor’s focus should be more focused on the patient,” she explains, with technology accelerating insight rather than adding friction.

As the episode closes, the focus turns toward what’s coming next—from predictive alerts to ambient data capture and clinician-ready dashboards. The message is clear: expanding monitoring isn’t just about placing more sensors. It’s about building intelligent systems that surface the right insight at the right time, helping care teams move from reactive response to proactive care.

Subscribe to this channel on Apple Podcasts and Spotify to hear more from the Intel Internet of Things Group.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

MD

Michelle Dawn Mooney is a media professional and host known for her work in broadcast journalism and B2B content.

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS Materials and Yokogawa ran an autonomous AI controller on a butadiene distillation column for 35 days and cut steam use 40%. It’s a real operations proof point. It also puts integration and governance gaps front and center.

  • 01A 35-day closed-loop run is a stronger autonomy proof point than a demo, it forces plants to prove handover, fallback, and KPIs over real feed and operating swings.
  • 02Steam reduction claims are compelling, but procurement and ops teams should pin vendors to baselines, operating envelopes, and how off-spec avoidance is measured.
  • 03Agentic AI is showing up as “work management” and “shift checklist” agents before it replaces control engineers, which shifts requirements toward clean, permissioned data access.

Sep 13, 2026

Novaspace sees 6,500+ Earth observation satellites by 2035, and value shifts to payload integration

Novaspace sees 6,500+ Earth observation satellites by 2035, and value shifts to payload integration

Novaspace forecasts more than 6,500 Earth observation satellites launching by 2035. It also projects $155.9 billion in manufacturing revenue, based on a SpaceNews-posted release dated Aug. 21, 2026. As defense-led demand shifts toward revisit rate and persistence, payload integration and fleet interoperability become the hard parts.

  • 01$155.9 billion is tied specifically to satellite manufacturing, not launch or ground, which should reshape how teams size supplier commitments and make-buy decisions.
  • 02Novaspace’s “skyscraper model” framing implies procurement power is shifting to payload integration, test capacity, and software-defined operations, even as the bus becomes more standardized.

Sep 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

MD
Michelle Dawn Mooney

Host & Healthcare Content Strategist

Michelle Dawn Mooney is a healthcare media professional and podcast host who covers topics across health, life sciences, and technology. She has hosted and produced content for MarketScale and other B2B media platforms, focusing on clinical innovation and industry trends. Her work spans interviews with executives and clinicians across the healthcare continuum.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512